Nov. 21, 2023

UCeed company aims to change standard of care for chronic pain

Zymedyne Therapeutics is one of 44 startups in UCeed's investment portfolio


Founded by scientists out of the Hotchkiss Brain Institute, Zymedyne Therapeutics is on a course to create a class of non-opioid and non-addictive pain medications. It's a “unicorn” that pharmaceutical companies have been madly chasing for years, and has the potential to help millions around the world.